Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...

The best eye wrinkle treatments rely a combination of moisturizers and retinol to smooth crow’s feet and other fine lines.

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 study titled A Phase 3 Randomized ...

Forte Biosciences Inc. (($FBRX)) announced an update on their ongoing clinical study. Forte Biosciences Inc. is conducting a clinical study titled ...

Recent vitiligo research has challenged long-held assumptions about skin cancer risk in patients with depigmented lesions. A ...

Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who ...

CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...

Experts explain how menopause impacts textured hair, the regrowth treatments that actually work, and what to know before you try one.

Incyte's growth potential and low valuation are driven by a strong pipeline and strategic focus. Read here for an investment analysis of INCY stock.